Hyperuricemia With or Without Gout Clinical Trial
Official Title: Safety and Efficacy Evaluation Study of FYU-981 Long-term Administration for Hyperuricemia With or Without Gout (Phase III Study)
The purpose of this study is confirmatory investigation of safety and efficacy of FYU-981 administered orally to hyperuricemic patients with and without gout for 34 or 58 weeks by the method of multicenter, open label and ascending dose regimen.
|Source||Fuji Yakuhin Co., Ltd.|
|Start date||December 2016|
|Completion date||October 24, 2018|